# Aquestive Therapeutics, Inc.: Form 8-K, filed Jun 11, 2025

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: 8-K
- Filed: 2025-06-11
- Accepted by EDGAR: Jun 11, 2025, 17:21 ET
- Period: 2025-06-11
- Accession: 0001628280-25-030804
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000162828025030804/aqst-20250611.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000162828025030804/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000162828025030804/aqst-20250611.htm

Filed Jun 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-030804. Last ingested by Listed: Nov 3, 2026, 19:40 ET. No prices; not investment advice.